Angela Basir, PharmD Candidate 2023

St. John's University

Disclosure(s): No financial relationships to disclose

Poster(s):

• 392 - Guideline adaptation of fidaxomicin as first-line therapy for Clostridioides difficile infection in institutions across the United States
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET